2025-07-29 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive Co (CL) based on the data you provided. I'll present it in English, starting with key figures and building up to a comprehensive overview.

## Colgate-Palmolive Co (CL) Stock Analysis

**Ticker:** CL
**Company Description:** Colgate-Palmolive Co. is a global consumer products company specializing in oral care, personal care, home care, and pet nutrition.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 13.90%
*   **VOO Cumulative Return:** 99.63%
*   **Absolute Divergence:** -85.2% (CL underperformed VOO)
*   **Relative Divergence:** 0.0 (This indicates CL's performance is at the very bottom end of its historical range compared to the S&P 500)

**Analysis:** Colgate-Palmolive has significantly underperformed the S&P 500 over the period considered. The relative divergence suggests this underperformance is unusually large compared to its historical trends.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| ---------- | ------- | ------- | ------- | ----- | ------ |
| 2015-2017  | 13.0%   | 4.5%    | -16.0%  | 0.0   | 61.1   |
| 2016-2018  | -11.0%  | 65.2%   | -29.0%  | 0.1   | 48.2   |
| 2017-2019  | 7.0%    | 65.2%   | -22.0%  | 0.1   | 55.8   |
| 2018-2020  | 18.0%   | 65.2%   | -2.0%   | 0.6   | 69.3   |
| 2019-2021  | 30.0%   | 58.6%   | -19.0%  | 0.7   | 69.2   |
| 2020-2022  | 7.0%    | 69.0%   | 5.0%    | 0.7   | 63.9   |
| 2021-2023  | 6.0%    | 69.0%   | -12.0%  | 0.8   | 64.6   |
| 2022-2024  | 13.0%   | 69.0%   | -12.0%  | 0.8   | 73.7   |
| 2023-2025  | 1.0%    | 70.6%   | -51.0%  | 0.3   | 70.1   |

*   **CAGR:** The Compound Annual Growth Rate (CAGR) fluctuates, with a recent significant drop to 1.0% for the 2023-2025 period.
*   **MDD:** The Maximum Drawdown (MDD) is relatively high in recent periods, peaking at 70.6% for 2023-2025, indicating substantial potential losses from peak to trough.
*   **Alpha:** Alpha is largely negative, suggesting the stock has consistently underperformed its benchmark on a risk-adjusted basis.  The recent -51.0% is particularly concerning.
*   **Beta:** Beta values are low, generally below 1, indicating the stock is less volatile than the overall market.  It implies that the stock is more stable.
*   **Cap(B):** Market capitalization fluctuates between $48.2 billion to $73.7 billion.

### 2. Recent Price Action

*   **Current Price:** $86.47
*   **Previous Close:** $87.93
*   **Change:** -$1.66
*   **5-day Moving Average:** $88.07
*   **20-day Moving Average:** $89.52
*   **60-day Moving Average:** $90.10

**Analysis:** The price is down from the previous close.  The price is below all three moving averages, suggesting a short-term downtrend.  The recent price drop of -$1.66 may indicate ongoing negative pressure.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3271 (Low Risk)
*   **RSI:** 23.90 (Oversold)
*   **PPO:** -0.19
*   **Hybrid Signal:** Cash_70%_Sell 69.9% of holdings (1169 shares - Caution - MRI:0.34) (Cash Ratio: 70% on 2025-07-16)
*   **Delta_Previous_Relative_Divergence:** -0.1 (Short-term decrease in relative divergence)
*   **Expected Return (%):** -3614.4 (Significant underperformance vs. S&P 500 over a long-term investment horizon)

**Analysis:**

*   The MRI indicates a Low Risk market environment.
*   The RSI is in oversold territory, which *could* signal a potential bounce, but given the other negative indicators, it's not a strong buy signal.
*   The PPO is negative, supporting the downtrend indication.
*   The Hybrid Signal strongly suggests selling a significant portion of holdings and increasing cash reserves, reflecting a bearish outlook.
*   The negative expected return is extremely concerning, suggesting substantial underperformance compared to the S&P 500 in the long term.

### 4. Recent News & Significant Events

*   **[2025-07-29] Major Business Developments, Regulatory Changes, or Market Events:** Suggests recent significant events influencing the company.
*   **[2025-07-25] Analyst Discussions on Performance and Outlook:** Indicates scrutiny and potentially mixed opinions.
*   **[2025-07-26] Notable Stock Volatility:** Confirms recent price fluctuations.
*   **[2025-07-28] Risks and Opportunities Highlighted:** Reinforces the need for cautious monitoring of the stock.

**Analysis:** Recent news points to significant events affecting Colgate-Palmolive, contributing to volatility and requiring careful monitoring. Analyst discussions suggest a mixed outlook, and the emphasis on both risks and opportunities highlights the need for a balanced perspective.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출      |
| ----------- | ----- | -------- |
| 2025-04-25 | 0.85  | 4.91 B$  |
| 2024-10-25 | 0.9   | 5.03 B$  |
| 2024-07-26 | 0.89  | 5.06 B$  |
| 2024-04-26 | 0.83  | 5.07 B$  |
| 2025-04-25 | 0.83  | 5.07 B$  |

**Analysis:** The EPS(Earning Per Share) values are relatively stable but 매출 (Revenue) shows a slight declining trend. The most recent quarter (2025-04-25) has a decrease in both EPS and revenue.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| ------------ | ---------- | ------------- |
| 2025-03-31   | $4.91B     | 60.82%        |
| 2024-12-31   | $4.95B     | 60.30%        |
| 2024-09-30   | $5.03B     | 61.08%        |
| 2024-06-30   | $5.06B     | 60.62%        |
| 2024-03-31   | $5.07B     | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
| ------------ | ---------- | --------- |
| 2025-03-31   | $0.36B     | 190.08%   |
| 2024-12-31   | $0.21B     | 348.58%   |
| 2024-09-30   | $0.43B     | 169.43%   |
| 2024-06-30   | $0.12B     | 594.31%   |
| 2024-03-31   | $0.23B     | 296.96%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue shows a slight declining trend over the past five quarters. Profit margins remain relatively stable, indicating that the company is managing its profitability despite the revenue decline.
*   **Capital and Profitability:** Equity fluctuates significantly, and Return on Equity (ROE) is extremely high. This suggests that the company is generating high returns on its equity, but the volatility in equity values should be further investigated.

### 7. Overall Assessment

Based on the provided data, the outlook for Colgate-Palmolive (CL) appears **bearish.**

**Key Concerns:**

*   **Significant Underperformance:** CL has drastically underperformed the S&P 500. The historical data shows poor returns of CL compared to S&P500.
*   **Declining Revenue Trend:** The revenue shows a decline in recent quarters, which is a major concern as it indicates that sales and earnings are declining.
*   **High Volatility in Equity:** The rapid changes in equity values could be a red flag and need to be further investigated.
*   **Low Risk Indicator and Selling Signal:** Even though the MRI is low risk, the hybrid signal points to selling the stock and increasing cash reserves.
*   **Negative Expected Return:** The expectation that the stock would underperform the S&P 500 in the future.
*   **Significant Events:** The recent news highlight a potential risks due to market events, regulatory changes, or major business developments.

**Recommendations:**

*   **Avoid Investing:** Given the underperformance, downtrend, and negative outlook, it would be prudent to avoid this stock.
*   **Monitor Closely:** If already holding the stock, closely monitor news, earnings reports, and further financial data for any signs of improvement.
*   **Seek Further Analysis:** Conduct a more in-depth fundamental analysis to understand the reasons behind the underperformance and assess long-term potential.

**Disclaimer:** This is based solely on the limited data you provided. A complete investment decision requires a more thorough investigation.
